The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

Eli Lilly (the company behind Mounjaro and Zepbound) just announced impressive phase 3 clinical trial results for a new weight loss medication, orforglipron, a GLP-1. Orforglipron is an oral ...

Researchers have developed the world’s first oral drug to target a form of cholesterol that has previously been untreatable and is largely caused by genetics, making it difficult to control by way of ...

What if treating obesity could be as easy as popping an effective pill? That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese — and fueled ...

WEST LAFAYETTE, Ind. – A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. Purdue University innovators ...

While insurance generally covers GLP-1s for the treatment of type 2 diabetes — though sometimes with limitations, depending on the insurance plan — far fewer insurance companies cover the medication ...

This builds on Form's work with both companies. Form was one of the first telemedicine obesity care providers included on Lilly's digital healthcare platform, LillyDirect (TM), and was among the first ...

The prescribed dosage for Revlimid (lenalidomide) may vary depending on a person’s individual treatment plan. Other factors, including your specific diagnosis and medical history, may affect your ...

WEST LAFAYETTE, Ind. - A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. The work is supported by the ...

New drug form may help treat osteoporosis, calcium-related disorders Date: January 7, 2021 Source: Purdue University Summary: Innovators have developed a stabilized form of human calcitonin, which is ...